Suppr超能文献

相似文献

1
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S140-S157. doi: 10.2337/dc23-S009.
2
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024.
Diabetes Care. 2024 Jan 1;47(Suppl 1):S158-S178. doi: 10.2337/dc24-S009.
3
6. Glycemic Targets: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. doi: 10.2337/dc23-S006.
4
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022.
Diabetes Care. 2022 Jan 1;45(Suppl 1):S125-S143. doi: 10.2337/dc22-S009.
5
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024.
Diabetes Care. 2024 Jan 1;47(Suppl 1):S111-S125. doi: 10.2337/dc24-S006.
6
7. Diabetes Technology: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S111-S127. doi: 10.2337/dc23-S007.
7
17. Diabetes Advocacy: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S279-S280. doi: 10.2337/dc23-S017.
8
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. doi: 10.2337/dc23-S002.
9
16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S267-S278. doi: 10.2337/dc23-S016.
10
13. Older Adults: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S216-S229. doi: 10.2337/dc23-S013.

引用本文的文献

2
Potential Therapeutic Benefits of Pepper Fruit Extract on Hyperglycemia and Dyslipidemia in Obese Type 2 Diabetic Mice.
Cureus. 2025 Aug 1;17(8):e89199. doi: 10.7759/cureus.89199. eCollection 2025 Aug.
4
Quality of antidiabetic medicines in 13 sub-Saharan African countries: a cross-sectional survey.
EClinicalMedicine. 2025 Aug 7;87:103405. doi: 10.1016/j.eclinm.2025.103405. eCollection 2025 Sep.
5
A Gamified Cardiometabolic Health Curriculum Utilizing a Student Response System for Internal Medicine Residents.
Cureus. 2025 Jul 11;17(7):e87718. doi: 10.7759/cureus.87718. eCollection 2025 Jul.
6
Metformin and Adipose Tissue: A Multifaceted Regulator in Metabolism, Inflammation, and Regeneration.
Endocrinol Metab (Seoul). 2025 Aug;40(4):523-538. doi: 10.3803/EnM.2025.2371. Epub 2025 Aug 8.
7
Loss of β-cell identity in human islets treated with glibenclamide.
Diabetes Obes Metab. 2025 Oct;27(10):5782-5792. doi: 10.1111/dom.16632. Epub 2025 Aug 4.
8
The Emerging Role of Anti-Hyperglycemic Agents for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.
Diabetes Metab Syndr Obes. 2025 Jul 23;18:2477-2491. doi: 10.2147/DMSO.S528569. eCollection 2025.
9
Evaluating GLP-1 receptor agonists versus metformin as first-line therapy for reducing dementia risk in type 2 diabetes.
BMJ Open Diabetes Res Care. 2025 Jul 22;13(4):e004902. doi: 10.1136/bmjdrc-2025-004902.
10
Decreased insulin dose-adjusted hemoglobin A1c in adults with cystic fibrosis-related diabetes treated with elexacaftor-tezacaftor-ivacaftor.
J Clin Transl Endocrinol. 2025 Jul 2;41:100407. doi: 10.1016/j.jcte.2025.100407. eCollection 2025 Sep.

本文引用的文献

4
Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation.
Lancet. 2022 Jan 22;399(10322):394-405. doi: 10.1016/S0140-6736(21)01919-X. Epub 2021 Sep 30.
6
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28.
8
RESULTS OF A 24-WEEK TRIAL OF TECHNOSPHERE INSULIN VERSUS INSULIN ASPART IN TYPE 2 DIABETES.
Endocr Pract. 2021 Jan;27(1):38-43. doi: 10.1016/j.eprac.2020.11.002. Epub 2020 Nov 17.
9
Overbasalization: Addressing Hesitancy in Treatment Intensification Beyond Basal Insulin.
Clin Diabetes. 2020 Jul;38(3):304-310. doi: 10.2337/cd19-0061.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验